ShanghaiTech University Knowledge Management System
In situ reprogramming of cardiac fibroblasts into cardiomyocytes in mouse heart with chemicals | |
2024-06-01 | |
发表期刊 | ACTA PHARMACOLOGICA SINICA (IF:6.9[JCR-2023],7.6[5-Year]) |
ISSN | 1671-4083 |
EISSN | 1745-7254 |
发表状态 | 已发表 |
DOI | 10.1038/s41401-024-01308-6 |
摘要 | Cardiomyocytes are terminal differentiated cells and have limited ability to proliferate or regenerate. Condition like myocardial infarction causes massive death of cardiomyocytes and is the leading cause of death. Previous studies have demonstrated that cardiac fibroblasts can be induced to transdifferentiate into cardiomyocytes in vitro and in vivo by forced expression of cardiac transcription factors and microRNAs. Our previous study have demonstrated that full chemical cocktails could also induce fibroblast to cardiomyocyte transdifferentiation both in vitro and in vivo. With the development of tissue clearing techniques, it is possible to visualize the reprogramming at the whole-organ level. In this study, we investigated the effect of the chemical cocktail CRFVPTM in inducing in situ fibroblast to cardiomyocyte transdifferentiation with two strains of genetic tracing mice, and the reprogramming was observed at whole-heart level with CUBIC tissue clearing technique and 3D imaging. In addition, single-cell RNA sequencing (scRNA-seq) confirmed the generation of cardiomyocytes from cardiac fibroblasts which carries the tracing marker. Our study confirms the use of small molecule cocktails in inducing in situ fibroblast to cardiomyocyte reprogramming at the whole-heart level and proof-of-conceptly providing a new source of naturally incorporated cardiomyocytes to help heart regeneration. |
关键词 | cardiac transdifferentiation in situ transdifferentiation small molecules cardiomyocytes fibroblasts in vivo transdifferentiation |
URL | 查看原文 |
收录类别 | SCI |
语种 | 英语 |
资助项目 | Ministry of Science and Technology of China[ |
WOS研究方向 | Chemistry ; Pharmacology & Pharmacy |
WOS类目 | Chemistry, Multidisciplinary ; Pharmacology & Pharmacy |
WOS记录号 | WOS:001250425000001 |
出版者 | NATURE PUBL GROUP |
文献类型 | 期刊论文 |
条目标识符 | https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/398577 |
专题 | 生命科学与技术学院 生命科学与技术学院_特聘教授组_谢欣组 生命科学与技术学院_博士生 |
通讯作者 | Xie, Xin |
作者单位 | 1.Chinese Acad Sci, Natl Ctr Drug Screening, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China 2.Univ Chinese Acad Sci, Sch Pharm, Beijing 100049, Peoples R China 3.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China 4.Bohai Rim Adv Res Inst Drug Discovery, Shandong Lab Yantai Drug Discovery, Yantai 264117, Peoples R China 5.Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Pharmaceut Sci & Technol, Hangzhou 310024, Peoples R China |
通讯作者单位 | 生命科学与技术学院 |
推荐引用方式 GB/T 7714 | Chen, Zi-yang,Ji, Si-jia,Huang, Chen-wen,et al. In situ reprogramming of cardiac fibroblasts into cardiomyocytes in mouse heart with chemicals[J]. ACTA PHARMACOLOGICA SINICA,2024. |
APA | Chen, Zi-yang.,Ji, Si-jia.,Huang, Chen-wen.,Tu, Wan-zhi.,Ren, Xin-yue.,...&Xie, Xin.(2024).In situ reprogramming of cardiac fibroblasts into cardiomyocytes in mouse heart with chemicals.ACTA PHARMACOLOGICA SINICA. |
MLA | Chen, Zi-yang,et al."In situ reprogramming of cardiac fibroblasts into cardiomyocytes in mouse heart with chemicals".ACTA PHARMACOLOGICA SINICA (2024). |
条目包含的文件 | ||||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 |
修改评论
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。